Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: BioNote, Inc.

Market Cap 47TCr 31Cr 27Cr 25Cr 23Cr 43Cr 2.93TCr 44Cr 290.91Cr 112.89Cr 1.42TCr 115.53Cr 113.02Cr 4.93TCr P/E ratio 2024
8.69x
P/E ratio 2025 -6.32x
Enterprise value 13TCr 8.79Cr 7.6Cr 7Cr 6.56Cr 12Cr 837.88Cr 12Cr 83Cr 32Cr 405.24Cr 33Cr 32Cr 1.41TCr EV / Sales 2024
0.77x
EV / Sales 2025 1.84x
Free-Float
12.55%
Yield 2024
4.25%
Yield 2025 -
1 day+2.88%
1 week-2.52%
Current month-4.91%
1 month-6.72%
3 months-12.76%
6 months-18.28%
Current year-14.99%
1 week 4,435
Extreme 4435
4,850
1 month 4,435
Extreme 4435
5,220
Current year 4,435
Extreme 4435
6,260
1 year 4,435
Extreme 4435
6,320
3 years 3,800
Extreme 3800
6,460
5 years 3,800
Extreme 3800
11,700
10 years 3,800
Extreme 3800
11,700
Manager TitleAgeSince
Chief Executive Officer 58 01/08/2020
Director of Finance/CFO 54 01/04/2021
Corporate Officer/Principal 50 01/05/2017
Director TitleAgeSince
Chairman 65 01/03/2023
Director/Board Member 58 01/08/2020
Director/Board Member 69 18/12/2020
Date Insider Type Main position Quantity % Market Cap.
05/25/05Free 1,00,00,000 9.8058%
05/25/05Don

Chairman

1,00,00,000 9.8058%
14/24/14Others 67,29,843 6.5991%
Change 5-day change 1-year change 3-year change Capi.($)
+2.88%-2.52%-8.28%-14.68% 29Cr
+5.56%+4.64%-38.47%-55.64% 211.99Cr
+2.19%-2.22%-59.98%-87.55% 164.17Cr
+4.31%-2.79%-39.32% - 5.49Cr
Average +3.73%-0.72%-36.52%-52.63% 102.76Cr
Weighted average by Cap. +4.01%+1.29%-44.92%-65.59%

Financials

2024 2025
Net sales 10TCr 6.72Cr 5.81Cr 5.36Cr 5.02Cr 9.38Cr 640.86Cr 9.55Cr 64Cr 25Cr 309.95Cr 25Cr 25Cr 1.08TCr 12TCr 7.74Cr 6.69Cr 6.17Cr 5.78Cr 11Cr 737.78Cr 11Cr 73Cr 28Cr 356.82Cr 29Cr 28Cr 1.24TCr
Net income 5.53TCr 3.61Cr 3.13Cr 2.88Cr 2.7Cr 5.04Cr 344.57Cr 5.13Cr 34Cr 13Cr 166.65Cr 14Cr 13Cr 579.12Cr -8.75TCr -5.72Cr -4.95Cr -4.56Cr -4.27Cr -7.98Cr -545.57Cr -8.13Cr -54Cr -21Cr -263.86Cr -21Cr -21Cr -916.94Cr
Net Debt -40TCr -26Cr -23Cr -21Cr -20Cr -37Cr -2.5TCr -37Cr -248.22Cr -96Cr -1.21TCr -99Cr -96Cr -4.21TCr -34TCr -22Cr -19Cr -18Cr -16Cr -31Cr -2.1TCr -31Cr -207.83Cr -81Cr -1.01TCr -83Cr -81Cr -3.52TCr
Logo BioNote, Inc.
BioNote Inc is a Korea-based company principally engaged in the bio-contents business. The Company is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The Company is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.
Employees
298
Date Price Change Volume
09/26/09 4,650.00 +2.88% 84,339
08/26/08 4,520.00 -3.62% 73,058
05/26/05 4,690.00 -0.53% 42,553
04/26/04 4,715.00 -1.15% 68,754
02/26/02 4,770.00 +0.32% 86,689
  1. Stock Market
  2. Stocks
  3. A377740 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW